Cargando…

Rosiglitazone Enhances Apolipoprotein M (Apom) Expression in Rat's Liver

Apolipoprotein M (APOM) has been suggested as a vasculoprotective constituent of high density lipoprotein (HDL), which plays a crucial role behind the mechanism of HDL-mediated anti-atherosclerosis. Previous studies demonstrated that insulin resistance could associate with decreased APOM expressions...

Descripción completa

Detalles Bibliográficos
Autores principales:	Luo, Guanghua, Feng, Yuehua, Zhang, Jun, Mu, Qinfeng, Shi, Yuanping, Qin, Li, Zheng, Lu, Berggren-Söderlund, Maria, Nilsson-Ehle, Peter, Zhang, Xiaoying, Xu, Ning
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2014
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4135224/ https://www.ncbi.nlm.nih.gov/pubmed/25136257 http://dx.doi.org/10.7150/ijms.8330

Ejemplares similares

Intralipid Decreases Apolipoprotein M Levels and Insulin Sensitivity in Rats
por: Zheng, Lu, et al.
Publicado: (2014)

Decreased Activities of Apolipoprotein M Promoter Are Associated with the Susceptibility to Coronary Artery Diseases
por: Zheng, Lu, et al.
Publicado: (2014)

Expression and localization of apolipoprotein M in human colorectal tissues
por: Luo, Guanghua, et al.
Publicado: (2010)

Hyperglycemia-induced downregulation of apolipoprotein M expression is not via the hexosamine pathway
por: Jiang, Bo, et al.
Publicado: (2015)

Effects of simvastatin on apolipoprotein M in vivo and in vitro
por: Zhang, Xiaoying, et al.
Publicado: (2011)

Apolipoprotein M
por: Luo, Guanghua, et al.
Publicado: (2004)

TO901317 regulating apolipoprotein M expression mediates via the farnesoid X receptor pathway in Caco-2 cells
por: Zhu, Chunhua, et al.
Publicado: (2011)

Determination of single-nucleotide polymorphism in the proximal promoter region of apolipoprotein M gene in coronary artery diseases
por: Zheng, Lu, et al.
Publicado: (2009)

Increased expression levels of inflammatory cytokines and adhesion molecules in lipopolysaccharide-induced acute inflammatory apoM(−/−) mice
por: Shi, Yuanping, et al.
Publicado: (2020)

Non-negligible factors in studying the ApoM-S1P axis using EA.hy926 cells
por: Shi, Yuanping, et al.
Publicado: (2020)

Increased plasma apoM levels in the patients suffered from hepatocellular carcinoma and other chronic liver diseases
por: Jiang, Jingting, et al.
Publicado: (2008)

Decreased Splenic CD4(+) T-Lymphocytes in Apolipoprotein M Gene Deficient Mice
por: Wang, Zhigang, et al.
Publicado: (2015)

Apolipoprotein M Gene (APOM) Polymorphism Modifies Metabolic and Disease Traits in Type 2 Diabetes
por: Zhou, Jun-Wei, et al.
Publicado: (2011)

A Novel Perspective on the ApoM-S1P Axis, Highlighting the Metabolism of ApoM and Its Role in Liver Fibrosis and Neuroinflammation
por: Hajny, Stefan, et al.
Publicado: (2017)

The FoxOs are in the ApoM house
por: Linton, MacRae F., et al.
Publicado: (2022)

Binding Characteristics of Sphingosine-1-Phosphate to ApoM hints to Assisted Release Mechanism via the ApoM Calyx-Opening
por: Zhang, Hansi, et al.
Publicado: (2016)

17β-estradiol regulates the expression of apolipoprotein M through estrogen receptor α-specific binding motif in its promoter
por: Wei, Jiang, et al.
Publicado: (2017)

ApoM is an important potential protective factor in the pathogenesis of primary liver cancer
por: Bai, Yaping, et al.
Publicado: (2021)

Functional Study of -724I/D Polymorphism in Apolipoprotein M (apoM) Gene Promoter Region and its Association with Myocardial Infarction
por: Guo, Hua, et al.
Publicado: (2015)

Apolipoprotein M inhibits proliferation and migration of larynx carcinoma cells
por: Xue, Haixiang, et al.
Publicado: (2020)

Apolipoprotein M could inhibit growth and metastasis of SMMC7721 cells via vitamin D receptor signaling
por: Yu, Miaomei, et al.
Publicado: (2019)

Apolipoprotein M promotes growth and inhibits apoptosis of colorectal cancer cells through upregulation of ribosomal protein S27a
por: Mu, Qinfeng, et al.
Publicado: (2021)

Lipid synthesis and secretion in HepG2 cells is not affected by ACTH
por: Skoog, Maria, et al.
Publicado: (2010)

Insulin Resistance in Apolipoprotein M Knockout Mice is Mediated by the Protein Kinase Akt Signaling Pathway
por: Yao, Shuang, et al.
Publicado: (2020)

Correlation analysis between ApoM gene-promoter polymorphisms and coronary heart disease
por: Zhang, Yao, et al.
Publicado: (2016)

The apoM/S1P Complex—A Mediator in Kidney Biology and Disease?
por: Bisgaard, Line S., et al.
Publicado: (2021)

ApoM binds endotoxin contributing to neutralization and clearance by High Density Lipoprotein
por: Mousa, Hanaa, et al.
Publicado: (2023)

ApoM regulates PFKL through the transcription factor SREBF1 to inhibit the proliferation, migration and metastasis of liver cancer cells
por: Zhang, Xiao, et al.
Publicado: (2022)

Apolipoprotein M promotes the anti-inflammatory effect of high-density lipoprotein by binding to scavenger receptor BI
por: Yao, Shuang, et al.
Publicado: (2020)

Endothelial Spns2 and ApoM Regulation of Vascular Tone and Hypertension Via Sphingosine‐1‐Phosphate
por: Del Gaudio, Ilaria, et al.
Publicado: (2021)

Meta-Analysis on the Correlation Between APOM rs805296 Polymorphism and Risk of Coronary Artery Disease
por: Sun, HongYan, et al.
Publicado: (2016)

Apolipoprotein M promotes cholesterol uptake and efflux from mouse macrophages
por: Yao, Shuang, et al.
Publicado: (2021)

Apolipoprotein M overexpression through adeno‐associated virus gene transfer improves insulin secretion and insulin sensitivity in Goto‐Kakizaki rats
por: Yu, Yang, et al.
Publicado: (2020)

Pioglitazone versus Rosiglitazone: Effects on Lipids, Lipoproteins, and Apolipoproteins in Head-to-Head Randomized Clinical Studies
por: Deeg, Mark A., et al.
Publicado: (2008)

Influence of liver cancer on lipid and lipoprotein metabolism
por: Jiang, Jingting, et al.
Publicado: (2006)

Leukemia and rosiglitazone
por: Yavasoglu, Irfan, et al.
Publicado: (2016)

LncRNA TUG1 regulates ApoM to promote atherosclerosis progression through miR‐92a/FXR1 axis
por: Yang, Liu, et al.
Publicado: (2020)

Dihydrocapsaicin down-regulates apoM expression through inhibiting Foxa2 expression and enhancing LXRα expression in HepG2 cells
por: Zhao, Jia-Yi, et al.
Publicado: (2014)

HDL-associated ApoM is anti-apoptotic by delivering sphingosine 1-phosphate to S1P1 & S1P3 receptors on vascular endothelium
por: Ruiz, Mario, et al.
Publicado: (2017)

The Janus face of rosiglitazone
por: Pich, Christine, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_20eo16d49r878ebo940bk8u84a